Edition:
United States

Alimera Sciences Inc (ALIM.O)

ALIM.O on Consolidated Issue listed on NASDAQ Global Market

1.40USD
24 Apr 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.40
Open
$1.45
Day's High
$1.45
Day's Low
$1.38
Volume
326,462
Avg. Vol
542,107
52-wk High
$2.66
52-wk Low
$1.01

Select another date:

Mon, Mar 13 2017

BRIEF-Alimera Sciences signs agreement for exclusive distributor of Iluvien in Spain

* Alimera Sciences signs agreement for exclusive distributor of Iluvien in Spain

BRIEF-Alimera Sciences Q4 adjusted non-gaap loss per share $0.10

* Alimera sciences reports record fourth quarter and full year 2016 financial results

BRIEF-Alimera Sciences and Knight Therapeutics file new drug submission for iluvien in Canada

* Alimera Sciences and Knight Therapeutics announce filing of new drug submission for iluvien in Canada

BRIEF-Alimera Sciences says its unit Alimera Sciences Ltd received pricing, reimbursement decree for ILUVIEN on Jan. 11

* Alimera Sciences-unit Alimera Sciences received pricing and reimbursement decree for ILUVIEN from Agenzia Italiana Del Farmaco (AIFA) on Jan 11, 2017 Source text for Eikon: Further company coverage:

BRIEF-Stonepine Capital LP reports 5.4 pct passive stake in Alimera Sciences

* Stonepine Capital LP reports 5.4 percent passive stake in Alimera Sciences Inc as of Nov 7 - sec filing Source text : http://bit.ly/2eKIZdy Further company coverage:

BRIEF-Alimera Sciences reports Q3 loss per share $0.16

* Q3 earnings per share view $-0.11, revenue view $10.5 million -- Thomson Reuters I/B/E/S

BRIEF-Alimera Sciences begins selling iluvien in the Middle East

* Alimera Sciences begins selling iluvien in the middle east

Select another date:

More From Around the Web